RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCI SCIE SCOPUS

      Apoptosis and Proliferation in Paired Primary Colorectal Adenocarcinomas and Their Liver Metastases

      한글로보기

      https://www.riss.kr/link?id=A101617436

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      The proliferation potentials and the level of apoptosis were compared in paired primary colorectal adenocarcinomas and their liver metastases within each individual. From a total of 22 patients 44 specimens of paired primary and metastatic tumors were obtained for analysis. The levels of spontaneous apoptosis (a spontaneous apoptosis index, SAI: % apoptotic nuclei among a total of 1000 nuclei) and of proliferation (KI-67 index: % positively stained cells for KI-67 among a total of 1000 cells) were analyzed between primary and metastatic tumors. Survival rates and its relationship with the clinical parameters were also analyzed. The overall survival rate at 5 years was 16.9% with the median survival time of 45 months. T-stage (p=0.005) and time to liver metastasis (synchronous versus metachronous, p=0.03) showed statistical significance in relation to survival. The mean SAI of primary tumors was 1.35±0.25, which was not statistically different from the 1.58±0.18 of metastatic tumors (p=0.33). The mean KI-67 indices in primary and metastatic tumors were 23.9±3.4 and 16.4±2.5, respectively, and this difference was statistically significant (p=0.016). Subset analysis showed significant difference in the KI-67 index in the synchronous group but not in the metachronous group. No significant difference was shown in the relative ratios of apoptosis to proliferation between the primary tumor and the metastasis within each individual. The results in this study may partly explain the indolent behavior of liver metastasis from colorectal cancer and provides a rationale for the active treatment of metastatic tumors as well as of primary disease.
      번역하기

      The proliferation potentials and the level of apoptosis were compared in paired primary colorectal adenocarcinomas and their liver metastases within each individual. From a total of 22 patients 44 specimens of paired primary and metastatic tumors were...

      The proliferation potentials and the level of apoptosis were compared in paired primary colorectal adenocarcinomas and their liver metastases within each individual. From a total of 22 patients 44 specimens of paired primary and metastatic tumors were obtained for analysis. The levels of spontaneous apoptosis (a spontaneous apoptosis index, SAI: % apoptotic nuclei among a total of 1000 nuclei) and of proliferation (KI-67 index: % positively stained cells for KI-67 among a total of 1000 cells) were analyzed between primary and metastatic tumors. Survival rates and its relationship with the clinical parameters were also analyzed. The overall survival rate at 5 years was 16.9% with the median survival time of 45 months. T-stage (p=0.005) and time to liver metastasis (synchronous versus metachronous, p=0.03) showed statistical significance in relation to survival. The mean SAI of primary tumors was 1.35±0.25, which was not statistically different from the 1.58±0.18 of metastatic tumors (p=0.33). The mean KI-67 indices in primary and metastatic tumors were 23.9±3.4 and 16.4±2.5, respectively, and this difference was statistically significant (p=0.016). Subset analysis showed significant difference in the KI-67 index in the synchronous group but not in the metachronous group. No significant difference was shown in the relative ratios of apoptosis to proliferation between the primary tumor and the metastasis within each individual. The results in this study may partly explain the indolent behavior of liver metastasis from colorectal cancer and provides a rationale for the active treatment of metastatic tumors as well as of primary disease.

      더보기

      참고문헌 (Reference)

      1 "The role of postoperative adjuvant radiation therapy to primary site in rectal cancer patients with synchronous liver metastasis" 11 : 103-108, 1993

      2 "Survival after liver resection for cancer" 26 : 493-502, 1970

      3 "Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients" 38 : 1-7, 1997

      4 "Resistance to apoptosis is increased during metastatic dissemination of colon cancer" 19 : 175-180, 2002

      5 "Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Results in 123 patients" 230 : 1-8, 1999

      6 "Quality of life and survival with continuous hepatic-artery floxiuridine infusion for colorectal liver metastases" 344 : 1255-1260, 1994

      7 "Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer" 228 : 201-208, 1998

      8 "Metastases in carcinoma: Analysis of 1000 autopsied cases" 3 : 74-85, 1950

      9 "Liver resection for colorectal metastases" 15 : 938-946, 1997

      10 "Kinetics of normal, preneoplastic, and neoplastic colonic epithelium. In: Moyer MP, Poste GH, editors. Colon cancer cells" San Diego, CA: Academic Press 41-61, 1990

      1 "The role of postoperative adjuvant radiation therapy to primary site in rectal cancer patients with synchronous liver metastasis" 11 : 103-108, 1993

      2 "Survival after liver resection for cancer" 26 : 493-502, 1970

      3 "Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients" 38 : 1-7, 1997

      4 "Resistance to apoptosis is increased during metastatic dissemination of colon cancer" 19 : 175-180, 2002

      5 "Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Results in 123 patients" 230 : 1-8, 1999

      6 "Quality of life and survival with continuous hepatic-artery floxiuridine infusion for colorectal liver metastases" 344 : 1255-1260, 1994

      7 "Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer" 228 : 201-208, 1998

      8 "Metastases in carcinoma: Analysis of 1000 autopsied cases" 3 : 74-85, 1950

      9 "Liver resection for colorectal metastases" 15 : 938-946, 1997

      10 "Kinetics of normal, preneoplastic, and neoplastic colonic epithelium. In: Moyer MP, Poste GH, editors. Colon cancer cells" San Diego, CA: Academic Press 41-61, 1990

      11 "Inhibition of apoptosis during development of colorectal cancer" 55 : 1811-1816, 1995

      12 "Indications of recurrence following cryotherapy for hepatic metastases from colorectal cancer" 86 : 234-240, 1999

      13 "Increased apoptosis in metastatic human colonic adenocarcinomas" 1 : 58-63, 2002

      14 "Hepatic resection for metastases of the colon and rectum" 162 : 109-113, 1986

      15 "Hepatic metastases: percutaneous radiofrequency ablation of liver metastases: treatment and follow-up in 16 patients" 202 : 803-808, 1997

      16 "Hepatic arterial infusion of floxiuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial" 10 : 1112-1118, 1992

      17 "Growth rate of hepatic metastases in colorectal carcinoma" 75 : 641-644, 1988

      18 "Frequency of apoptosis related inversely to invasiveness and metastatic activity in human colorectal cancer" 431 : 241-248, 1997

      19 "Failure pattern following curative resection of colonic carcinoma" 200 : 680-690, 1984

      20 "Development of apoptosis in irradiated murine tumors of different histologies" 64 : 583-591, 1993

      21 "Cyclooxygenase-2 expression in colorectal cancer liver metastases" 18 : 21-27, 2000

      22 "Current targets for anticancer drug discovery" 4 : 159-179, 2003

      23 "Comparative study of various biological parameters, including expression of surviving, between primary and metastatic human colonic adenocarcinomas" 22 : 1769-1776, 2002

      24 "Assessment of biomarkers in paired primary and recurrent colorectal adenocarcinomas" 45 : 1167-1173, 1999

      25 "Apoptotic cell death and its relationship to carcinogenesis in colorectal carcinoma" 77 : 1711-1716, 1996

      26 "Apoptosis occurs more frequently in metastatic foci than primary lesions of human colorectal carcinomas: analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling" 65 : 173-177, 1996

      27 "Anticancer drugs of tomorrow: apoptotic pathway as targets for drug design" 15 : 62-77, 2003

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-05-31 학술지등록 한글명 : Yonsei Medical Journal
      외국어명 : Yonsei Medical Journal
      KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2000-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.42 0.3 0.99
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.83 0.72 0.546 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼